ES8800048A1 - Mejoras introducidas en un procedimiento para la preparacion de piroxicam o una sal farmaceuticamente aceptable del mismo en forma de composicion anti-inflamatoria mejorada. - Google Patents

Mejoras introducidas en un procedimiento para la preparacion de piroxicam o una sal farmaceuticamente aceptable del mismo en forma de composicion anti-inflamatoria mejorada.

Info

Publication number
ES8800048A1
ES8800048A1 ES551390A ES551390A ES8800048A1 ES 8800048 A1 ES8800048 A1 ES 8800048A1 ES 551390 A ES551390 A ES 551390A ES 551390 A ES551390 A ES 551390A ES 8800048 A1 ES8800048 A1 ES 8800048A1
Authority
ES
Spain
Prior art keywords
piroxicam
procedure
preparation
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551390A
Other languages
English (en)
Spanish (es)
Other versions
ES551390A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8800048A1 publication Critical patent/ES8800048A1/es
Publication of ES551390A0 publication Critical patent/ES551390A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
ES551390A 1985-01-31 1986-01-29 Mejoras introducidas en un procedimiento para la preparacion de piroxicam o una sal farmaceuticamente aceptable del mismo en forma de composicion anti-inflamatoria mejorada. Expired ES8800048A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/696,686 US4559326A (en) 1985-01-31 1985-01-31 Antiinflammatory compositions and methods

Publications (2)

Publication Number Publication Date
ES8800048A1 true ES8800048A1 (es) 1987-11-01
ES551390A0 ES551390A0 (es) 1987-11-01

Family

ID=24798136

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551390A Expired ES8800048A1 (es) 1985-01-31 1986-01-29 Mejoras introducidas en un procedimiento para la preparacion de piroxicam o una sal farmaceuticamente aceptable del mismo en forma de composicion anti-inflamatoria mejorada.

Country Status (20)

Country Link
US (1) US4559326A (enExample)
EP (1) EP0190851B1 (enExample)
JP (1) JPS61176524A (enExample)
CN (1) CN1010550B (enExample)
AT (1) ATE49120T1 (enExample)
AU (1) AU558587B2 (enExample)
CA (1) CA1255593A (enExample)
DD (1) DD242749A5 (enExample)
DE (1) DE3667913D1 (enExample)
DK (1) DK165966C (enExample)
EG (1) EG17890A (enExample)
ES (1) ES8800048A1 (enExample)
GR (1) GR860248B (enExample)
HU (1) HU194736B (enExample)
IE (1) IE58368B1 (enExample)
IL (1) IL77742A0 (enExample)
NZ (1) NZ214985A (enExample)
PH (1) PH22206A (enExample)
PT (1) PT81933B (enExample)
ZA (1) ZA86689B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
JPH07116026B2 (ja) * 1987-07-07 1995-12-13 株式会社資生堂 ジクロフェナックナトリウム含有乳化外用剤
JP2964195B2 (ja) * 1992-04-28 1999-10-18 エスエス製薬株式会社 ピロキシカム錠及びその製造法
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
US6492334B1 (en) * 1999-12-30 2002-12-10 Robert James Generale Tri-compound analgesic for treating inflammation and pain
KR100406576B1 (ko) * 2001-06-23 2003-11-20 최후균 경피투여용 패취제
CN108309960A (zh) * 2018-04-24 2018-07-24 温州医科大学附属第医院 肌醇在制备抗炎药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2221128A2 (en) * 1973-03-13 1974-10-11 Fabre Sa Pierre Aspirin - polyol compsns. - contg. inositol, ribitol or glucuronic acid - free from ulcerogenic activity
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts

Also Published As

Publication number Publication date
NZ214985A (en) 1988-09-29
PH22206A (en) 1988-06-28
PT81933A (en) 1986-02-01
US4559326A (en) 1985-12-17
EP0190851B1 (en) 1990-01-03
CA1255593A (en) 1989-06-13
DK165966C (da) 1993-08-16
DK165966B (da) 1993-02-22
DE3667913D1 (de) 1990-02-08
GR860248B (en) 1986-05-29
JPH0314812B2 (enExample) 1991-02-27
DK45486A (da) 1986-08-01
HUT39605A (en) 1986-10-29
DD242749A5 (de) 1987-02-11
JPS61176524A (ja) 1986-08-08
EG17890A (en) 1991-03-30
ZA86689B (en) 1987-09-30
ES551390A0 (es) 1987-11-01
AU558587B2 (en) 1987-02-05
DK45486D0 (da) 1986-01-30
CN1010550B (zh) 1990-11-28
IL77742A0 (en) 1986-07-31
IE860269L (en) 1986-07-31
IE58368B1 (en) 1993-09-08
CN86100749A (zh) 1986-10-15
ATE49120T1 (de) 1990-01-15
AU5284286A (en) 1986-08-07
EP0190851A1 (en) 1986-08-13
HU194736B (en) 1988-03-28
PT81933B (pt) 1988-05-27

Similar Documents

Publication Publication Date Title
DZ615A1 (fr) Composés nouveaux.
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
DK381583A (da) Metylsubstituerede 4-metoxypyridin-n-oxyder
MY101791A (en) New benzimidazole derivatives
SE8300308L (sv) Nya 3-keto- 4,9,19-nor-stereoider, deras framstellning, deras anvendning som lekemedel, kompositioner innehallande dem och deras nya erhallna mellanprodukter
FR2373560A1 (fr) Nouveaux esters de steroide de la serie de l'androstane et de l'oestrane, et compositions pharmaceutiques les contenant
FI844468L (fi) Foerfarande foer framstaellning av fosfatidylserin-blandningar anvaendbara vid behandling av sjukdomar i det centrala nervsystemet.
ES2002432A6 (es) Procedimiento para la produccion de una mezcla de cemento conteniendo plastificantes
KR890003391A (ko) 칼슘 보충제
FR2362839A1 (fr) Derives de l'hydantoine et medicaments contenant ces substances
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
DK0506772T3 (da) Farmaceutisk præparat indeholdende et phosphosukker
FR2443471A1 (fr) Derives du type thiazolidine de la progesterone utiles notamment comme precurseurs de medicaments antiacne et antiseborrhee
NO853441L (no) Fremgangsmaate for fremstilling av benzofuransulfonamider.
BE900959A (fr) Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication.
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
KR920017668A (ko) 암 전이 억제 또는 예방 방법 및 이를 위한 제제
FR2444463A1 (fr) Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
IT1092070B (it) Valvola per l'erogazione separata di due componenti e per la loro miscelazione all'esterno della stessa
DE3667914D1 (de) Entzuendungshemmende zusammensetzungen und verfahren.
SE8704240D0 (sv) Analgesic preparations
ATE30152T1 (de) 1-methyl-5-nitro-imidazolin-derivate und diese enthaltende therapeutische zusammensetzungen.
NO179838C (no) Fremgangsmåte for fremstilling av S-(-)-3-morfolino-4-(3-tert-butylamino-2-hydroksypropoksy)-1,2,5-tiadiazol-hemihydrat
MX174093B (es) 1,1-DIOXIDOS DE 3,4-DIHIDRO-2-ALQUIL-3-OXO-N-ARIL-2H[1] BENZOTIENO[3,2-e]-1,2-TIAZINO-4-CARBOXIAMIDA

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519